JAZZ
Jazz Pharmaceuticals PLC
NASDAQ: JAZZ · HEALTHCARE · BIOTECHNOLOGY
$199.92
-1.99% today
Updated 2026-04-29
Market cap
$12.54B
P/E ratio
—
P/S ratio
2.94x
EPS (TTM)
$-5.83
Dividend yield
—
52W range
$98 – $207
Volume
1.0M
Jazz Pharmaceuticals PLC (JAZZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-57.35M | $-81.09M | $-130.23M | $-15.88M | $58.87M | $151.60M | $249.75M | $283.62M | $405.76M | $531.94M | $590.54M | $693.09M | $798.90M | $776.40M | $899.65M | $778.51M | $1.27B | $1.09B | $1.40B | $1.36B |
| Capital expenditures | $1.68M | $3.15M | $28.74M | $6.05M | $4.73M | $5.78M | $22.48M | $11.28M | $238.97M | $35.96M | $181.58M | $113.95M | $131.47M | $182.34M | $379.25M | $45.53M | $498.19M | $23.96M | $48.07M | $58.75M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $6.06M | $8.11M | $5.96M | $8.22M | $20.70M | $23.01M | $44.55M | $69.64M | $91.55M | $98.77M | $106.90M | $102.44M | $110.56M | $121.00M | $189.01M | $222.00M | $226.84M | $248.04M | $291.13M |
| Free cash flow | $-59.03M | $-84.24M | $-158.97M | $-21.93M | $54.14M | $145.82M | $227.28M | $272.34M | $166.79M | $495.99M | $408.95M | $579.14M | $667.43M | $594.07M | $520.39M | $732.98M | $773.78M | $1.07B | $1.35B | $1.30B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $6.40M | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $57.83M | $99.68M | $99.66M | $98.02M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $37.28M | $305.12M | $249.31M | $47.54M | $304.74M | $-622.82M | $20.07M | $-76.41M | — | $420.05M | $-463.11M | $296.26M | — | — | — |